Cytotoxic necrotizing factor 1 hinders colon tumorigenesis induced by colibactin-producing Escherichia coli in Apc^Min/+ mice

References

• Global Cancer Observatory [Internet]. 2021 [accessed 2021 Jan 4]. https://gco.iarc.fr/
   Google Scholar
• Zhang L, Shay JW. Multiple roles of APC and its therapeutic implications in colorectal cancer. J Natl Cancer Inst [Internet]. 2017;109(8). doi:10.1093/jnci/djw332.
   Google Scholar
• Gagnière J. Gut microbiota imbalance and colorectal cancer. WJG. 2016;22(2):501. doi:10.3748/wjg.v22.i2.501.
   PubMed Web of Science ®Google Scholar
• Schmidt TSB, Raes J, Bork P. The human gut microbiome: from association to modulation. Cell. 2018;172(6):1198–19. doi:10.1016/j.cell.2018.02.044.
   PubMed Web of Science ®Google Scholar
• Boleij A, Hechenbleikner EM, Goodwin AC, Badani R, Stein EM, Lazarev MG, Ellis B, Carroll KC, Albesiano E, Wick EC, et al. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis. 2015;60(2):208–215. doi:10.1093/cid/ciu787.
   PubMed Web of Science ®Google Scholar
• Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, Zhang D, Xia H, Xu X, Jie Z, et al. Gut microbiome development along the colorectal adenoma–carcinoma sequence. Nat Commun. 2015;6(1):6528. doi:10.1038/ncomms7528.
   PubMed Web of Science ®Google Scholar
• Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host & Microbe. 2013;14(2):207–215. doi:10.1016/j.chom.2013.07.007.
   PubMed Web of Science ®Google Scholar
• Lucas C, Barnich N, Nguyen NH. Microbiota, inflammation and colorectal cancer. Int J Mol Sci. 2017;18(6):1310. doi:10.3390/ijms18061310.
   PubMed Web of Science ®Google Scholar
• Tilg H, Adolph TE, Gerner RR, Moschen AR. The intestinal microbiota in colorectal cancer. Cancer Cell. 2018;33(6):954–964. doi:10.1016/j.ccell.2018.03.004.
   PubMed Web of Science ®Google Scholar
• Li Y, Kundu P, Seow SW, de Matos CT, Aronsson L, Chin KC, Kärre K, Pettersson S, Greicius G. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APC Min/+ mice. Carcinogenesis. 2012;33:1231–1238. doi:10.1093/carcin/bgs137.
   PubMed Web of Science ®Google Scholar
• Wong SH, Zhao L, Zhang X, Nakatsu G, Han J, Xu W, Xiao X, Kwong TNY, Tsoi H, WKK W, et al. Gavage of fecal samples from patients with colorectal cancer promotes intestinal carcinogenesis in germ-free and conventional mice. Gastroenterology. 2017;153(6):1621–1633.e6. doi:10.1053/j.gastro.2017.08.022.
   PubMed Web of Science ®Google Scholar
• Orberg ET, Fan H, Tam AJ, Dejea CM, Destefano-Shields CE, Wu S, Chung L, Finard BB, Wu X, Fathi P, et al. The myeloid immune signature of enterotoxigenic bacteroides fragilis-induced murine colon tumorigenesis. Mucosal Immunol. 2017;10(2):421–433. doi:10.1038/mi.2016.53.
   PubMed Web of Science ®Google Scholar
• Bossuet-Greif N, Vignard J, Taieb F, Mirey G, Dubois D, Petit C, Oswald E, Nougayrède J-P, Galan JE, Sansonetti PJ. The colibactin genotoxin generates DNA interstrand cross-links in infected cells. mBio. 2018;9(2):e02393–17. mbio/9/2/mBio.02393-17.atom. doi:10.1128/mBio.02393-17.
   PubMed Web of Science ®Google Scholar
• Nougayrède J-P, Taieb F, De Rycke J, Oswald E. Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol. 2005;13(3):103–110. doi:10.1016/j.tim.2005.01.002.
   PubMed Web of Science ®Google Scholar
• Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J, Darfeuille-Michaud A, Pezet D, Bonnet R, Battista JR. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS One. 2013;8(2):e56964. doi:10.1371/journal.pone.0056964.
   PubMed Web of Science ®Google Scholar
• Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan T-J, Campbell BJ, Abujamel T, Dogan B, Rogers AB, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012;338(6103):120–123. doi:10.1126/science.1224820.
   PubMed Web of Science ®Google Scholar
• Cuevas-Ramos G, Petit CR, Marcq I, Boury M, Oswald E, Nougayrède J-P. Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells. Proc Natl Acad Sci USA. 2010;107(25):11537–11542. doi:10.1073/pnas.1001261107.
   PubMed Web of Science ®Google Scholar
• Iftekhar A, Berger H, Bouznad N, Heuberger J, Boccellato F, Dobrindt U, Hermeking H, Sigal M, Meyer TF. Genomic aberrations after short-term exposure to colibactin-producing E. coli transform primary colon epithelial cells. Nat Commun. 2021;12(1):1003. doi:10.1038/s41467-021-21162-y.
   PubMed Web of Science ®Google Scholar
• Nougayrède J-P, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, Buchrieser C, Hacker J, Dobrindt U, Oswald E. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science. 2006;313(5788):848–851. doi:10.1126/science.1127059.
   PubMed Web of Science ®Google Scholar
• Pleguezuelos-Manzano C, Puschhof J, Rosendahl Huber A, van Hoeck A, Wood HM, Nomburg J, Gurjao C, Manders F, Dalmasso G, Stege PB, et al. Mutational signature in colorectal cancer caused by genotoxic pks+E. Coli. Nature. 2020;580:269–273.
   PubMed Web of Science ®Google Scholar
• Dziubańska-Kusibab PJ, Berger H, Battistini F, Bouwman BAM, Iftekhar A, Katainen R, Cajuso T, Crosetto N, Orozco M, Aaltonen LA, et al. Colibactin DNA-damage signature indicates mutational impact in colorectal cancer. Nat Med. 2020;26(7):1063–1069. doi:10.1038/s41591-020-0908-2.
   PubMed Web of Science ®Google Scholar
• Cougnoux A, Dalmasso G, Martinez R, Buc E, Delmas J, Gibold L, Sauvanet P, Darcha C, Déchelotte P, Bonnet M, et al. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut. 2014;63(12):1932–1942. doi:10.1136/gutjnl-2013-305257.
   PubMed Web of Science ®Google Scholar
• Bonnet M, Buc E, Sauvanet P, Darcha C, Dubois D, Pereira B, Déchelotte P, Bonnet R, Pezet D, Darfeuille-Michaud A. Colonization of the human gut by E. coli and colorectal cancer risk. Clin Cancer Res. 2014;20(4):859–867. doi:10.1158/1078-0432.CCR-13-1343.
   PubMed Web of Science ®Google Scholar
• Tomkovich S, Yang Y, Winglee K, Gauthier J, Mühlbauer M, Sun X, Mohamadzadeh M, Liu X, Martin P, Wang GP, et al. Locoregional effects of microbiota in a preclinical model of colon carcinogenesis. Cancer Res. 2017;77(10):2620–2632. doi:10.1158/0008-5472.CAN-16-3472.
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu G-Y, Osterreicher CH, Hung KE, et al. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature. 2012;491(7423):254–258. doi:10.1038/nature11465.
   PubMed Web of Science ®Google Scholar
• Cooper HS, Everley L, Chang W, Pfeiffer G, Lee B, Murthy S, Clapper ML. The role of mutant Apc in the development of dysplasia and cancer in the mouse model of dextran sulfate sodium–induced colitis. Gastroenterology. 2001;121(6):1407–1416. doi:10.1053/gast.2001.29609.
   PubMed Web of Science ®Google Scholar
• Dennis KL, Wang Y, Blatner NR, Wang S, Saadalla A, Trudeau E, Roers A, Weaver CT, Lee JJ, Gilbert JA, et al. Adenomatous polyps are driven by microbe-instigated focal inflammation and are controlled by IL-10–producing T cells. Cancer Res. 2013;73(19):5905–5913. doi:10.1158/0008-5472.CAN-13-1511.
   PubMed Web of Science ®Google Scholar
• Huang EH, Park JC, Appelman H, Weinberg AD, Banerjee M, Logsdon CD, Schmidt AM. Induction of inflammatory bowel disease accelerates adenoma formation in Min +/− mice. Surgery. 2006;139(6):782–788. doi:10.1016/j.surg.2005.11.005.
   PubMed Web of Science ®Google Scholar
• Ho M, Mettouchi A, Wilson BA, Lemichez E. CNF1-like deamidase domains: common Lego bricks among cancer-promoting immunomodulatory bacterial virulence factors. Pathog Dis. 2018;76(5):fty045. doi:10.1093/femspd/fty045.
   PubMed Web of Science ®Google Scholar
• Boyer L, Travaglione S, Falzano L, Gauthier NC, Popoff MR, Lemichez E, Fiorentini C, Fabbri A. Rac GTPase instructs nuclear factor-κB activation by conveying the SCF complex and IkBα to the ruffling membranes. Mol Biol Cell. 2004;15(3):1124–1133. doi:10.1091/mbc.e03-05-0301.
   PubMed Web of Science ®Google Scholar
• Falzano L, Quaranta MG, Travaglione S, Filippini P, Fabbri A, Viora M, Donelli G, Fiorentini C. Cytotoxic necrotizing factor 1 enhances reactive oxygen species-dependent transcription and secretion of proinflammatory cytokines in human uroepithelial cells. Infect Immun. 2003;71(7):4178–4181. doi:10.1128/IAI.71.7.4178-4181.2003.
   PubMed Web of Science ®Google Scholar
• Munro P, Flatau G, Doye A, Boyer L, Oregioni O, Mege J-L, Landraud L, Lemichez E. Activation and proteasomal degradation of rho GTPases by cytotoxic necrotizing factor-1 elicit a controlled inflammatory response. J Biol Chem. 2004;279(34):35849–35857. doi:10.1074/jbc.M401580200.
   PubMed Web of Science ®Google Scholar
• Fiorentini C, Fabbri A, Matarrese P, Falzano L, Boquet P, Malorni W. Hinderance of apoptosis and phagocytic behaviour induced by Escherichia coli cytotoxic necrotizing factor 1: two related activities in epithelial cells. Biochem Biophys Res Commun. 1997;241(2):341–346. doi:10.1006/bbrc.1997.7723.
   PubMed Web of Science ®Google Scholar
• Fiorentini C, Matarrese P, Straface E, Falzano L, Donelli G, Boquet P, Malorni W. Rho-dependent cell spreading activated by E.Coli cytotoxic necrotizing factor 1 hinders apoptosis in epithelial cells. Cell Death Differ. 1998;5(11):921–929. doi:10.1038/sj.cdd.4400422.
   PubMed Web of Science ®Google Scholar
• Falzano L, Filippini P, Travaglione S, Miraglia AG, Fabbri A, Fiorentini C. Escherichia coli cytotoxic necrotizing factor 1 blocks cell cycle G2/M transition in uroepithelial cells. Infect Immun. 2006;74(7):3765–3772. doi:10.1128/IAI.01413-05.
   PubMed Web of Science ®Google Scholar
• Fabbri A, Travaglione S, Rosadi F, Ballan G, Maroccia Z, Giambenedetti M, Guidotti M, Ødum N, Krejsgaard T, Fiorentini C. The Escherichia coli protein toxin cytotoxic necrotizing factor 1 induces epithelial mesenchymal transition. Cell Microbiol. 2020;22(2):e13138. doi:10.1111/cmi.13138.
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhang Z, Wei H, Wang J, Lv J, Zhang K, Keller ET, Yao Z, Wang Q. Cytotoxic necrotizing factor 1 promotes prostate cancer progression through activating the Cdc42–PAK1 axis. J Pathol. 2017;243(2):208–219. doi:10.1002/path.4940.
   PubMed Web of Science ®Google Scholar
• Gagnière J, Bonnin V, Jarrousse A-S, Cardamone E, Agus A, Uhrhammer N, Sauvanet P, Déchelotte P, Barnich N, Bonnet R, et al. Interactions between microsatellite instability and human gut colonization by Escherichia coli in colorectal cancer. Clin Sci. 2017;131(6):471–485. doi:10.1042/CS20160876.
   Web of Science ®Google Scholar
• Lucas C, Salesse L, Hoang MHT, Bonnet M, Sauvanet P, Larabi A, Godfraind C, Gagnière J, Pezet D, Rosenstiel P, et al. Autophagy oF intestinal epithelial cells inhibits colorectal carcinogenesis induced by colibactin-producing Escherichia coli in ApcMin/+ mice. Gastroenterology. 2020;158(5):1373–1388. doi:10.1053/j.gastro.2019.12.026.
   PubMed Web of Science ®Google Scholar
• Mah L-J, El-Osta A, Karagiannis TC. γH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia. 2010;24(4):679–686. doi:10.1038/leu.2010.6.
   PubMed Web of Science ®Google Scholar
• Feng Y, Mannion A, Madden CM, Swennes AG, Townes C, Byrd C, Marini RP, Fox JG. Cytotoxic Escherichia coli strains encoding colibactin and cytotoxic necrotizing factor (CNF) colonize laboratory macaques. Gut Pathog [Internet]. 2017;9(1). 10.1186/s13099-017-0220-y
   Google Scholar
• Fiorentini C, Arancia G, Caprioli A, Falbo V, Ruggeri FM, Donelli G. Cytoskeletal changes induced in HEp-2 cells by the cytotoxic necrotizing factor of Escherichia coli. Toxicon. 1988;26(11):1047–1056. doi:10.1016/0041-0101(88)90203-6.
   PubMed Web of Science ®Google Scholar
• Bouquet F, Muller C, Salles B. The loss of γH2AX signal is a marker of DNA double strand breaks repair only at low levels of DNA damage. Cell Cycle. 2006;5(10):1116–1122. doi:10.4161/cc.5.10.2799.
   PubMed Web of Science ®Google Scholar
• Secher T, Samba-Louaka A, Oswald E, Nougayrède J-P, Sherman M. Escherichia coli producing colibactin triggers premature and transmissible senescence in mammalian cells. PLOS ONE. 2013;8(10):17. doi:10.1371/journal.pone.0077157.
   Web of Science ®Google Scholar
• Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc. 2009;4(12):1798–1806. doi:10.1038/nprot.2009.191.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Aung KM, Uhlin BE, Wai SN. Reversible senescence of human colon cancer cells after blockage of mitosis/cytokinesis caused by the CNF1 cyclomodulin from Escherichia coli. Sci Rep. 2018;8(1):17780. doi:10.1038/s41598-018-36036-5.
   PubMedGoogle Scholar
• Moolmuang B, Tainsky MA. CREG1 enhances p16INK4a-induced cellular senescence. Cell Cycle. 2011;10(3):518–530. doi:10.4161/cc.10.3.14756.
   PubMed Web of Science ®Google Scholar
• Fabbri A, Travaglione S, Ballan G, Loizzo S, Fiorentini C. The cytotoxic necrotizing factor 1 from E. coli: a janus toxin playing with cancer regulators. Toxins (Basel). 2013;5(8):1462–1474. doi:10.3390/toxins5081462.
   PubMed Web of Science ®Google Scholar
• Desvaux M, Dalmasso G, Beyrouthy R, Barnich N, Delmas J, Bonnet R. Pathogenicity factors of genomic islands in intestinal and extraintestinal Escherichia coli. Front Microbiol. 2020;11:2065. doi:10.3389/fmicb.2020.02065.
   PubMedGoogle Scholar
• Doye A, Mettouchi A, Bossis G, Clément R, Buisson-Touati C, Flatau G, Gagnoux L, Piechaczyk M, Boquet P, Lemichez E. CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell. 2002;111(4):553–564. doi:10.1016/S0092-8674(02)01132-7.
   PubMed Web of Science ®Google Scholar
• Falzano L, Fiorentini C, Donneli G, Michel E, Kocks C, Cossart P, Cabanié L, Oswald E, Boquet P. Induction of phagocytic behaviour in human epithelial cells by Escherichia coli cytotoxic necrotizing factor type 1. Mol Microbiol. 1993;9(6):1247–1254. doi:10.1111/j.1365-2958.1993.tb01254.x.
   PubMed Web of Science ®Google Scholar
• Fabbri A, Travaglione S, Fiorentini C. Escherichia coli cytotoxic necrotizing factor 1 (CNF1): toxin biology, in Vivo applications and therapeutic potential. Toxins (Basel). 2010;2(2):283–296. doi:10.3390/toxins2020282.
   PubMed Web of Science ®Google Scholar
• Vannini E, Panighini A, Cerri C, Fabbri A, Lisi S, Pracucci E, Benedetto N, Vannozzi R, Fiorentini C, Caleo M, et al. The bacterial protein toxin, cytotoxic necrotizing factor 1 (CNF1) provides long-term survival in a murine glioma model. Bmc Cancer. 2014;14(1):449. doi:10.1186/1471-2407-14-449.
   PubMedGoogle Scholar
• Colarusso A, Maroccia Z, Parrilli E, Germinario EAP, Fortuna A, Loizzo S, Ricceri L, Tutino ML, Fiorentini C, Fabbri A. Cnf1 variants endowed with the ability to cross the blood–brain barrier: a new potential therapeutic strategy for glioblastoma. Toxins (Basel). 2020;12(5):E291. doi:10.3390/toxins12050291.
   PubMed Web of Science ®Google Scholar
• Vannini E, Mori E, Tantillo E, Schmidt G, Caleo M, Costa M. CTX-CNF1 recombinant protein selectively targets glioma Cells in vivo. Toxins (Basel). 2021;13(3):194. doi:10.3390/toxins13030194.
   PubMed Web of Science ®Google Scholar
• Dalmasso G, Cougnoux A, Delmas J, Darfeuille-Michaud A, Bonnet R. The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment. Gut Microbes. 2014;5(5):675–680. doi:10.4161/19490976.2014.969989.
   PubMed Web of Science ®Google Scholar
• Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759–771. doi:10.1038/nrc3611.
   PubMed Web of Science ®Google Scholar
• Salesse L, Lucas C, Hoang MHT, Sauvanet P, Rezard A, Rosenstiel P, Damon-Soubeyrand C, Barnich N, Godfraind C, Dalmasso G, et al. Colibactin-producing Escherichia coli induce the formation of invasive carcinomas in a chronic inflammation-associated mouse model. Cancers Basel. 2021;13(9):2060. doi:10.3390/cancers13092060.
   PubMed Web of Science ®Google Scholar
• Dominguez C, McCampbell KK, David JM, Palena C. Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer. JCI Insight [Internet]. 2021 Jan 18;2(21). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5752275/.
   PubMed Web of Science ®Google Scholar
• Alfaro C, Teijeira A, Oñate C, Pérez G, Sanmamed MF, Andueza MP, Alignani D, Labiano S, Azpilikueta A, Rodriguez-Paulete A, et al. Tumor-produced interleukin-8 attracts human myeloid-derived suppressor cells and elicits extrusion of Neutrophil Extracellular Traps (NETs). Clin Cancer Res. 2016;22(15):3924–3936. doi:10.1158/1078-0432.CCR-15-2463.
   PubMed Web of Science ®Google Scholar
• Fernando RI, Castillo MD, Litzinger M, Hamilton DH, Palena C. IL-8 signaling plays a critical role in the epithelial–mesenchymal transition of human carcinoma cells. Cancer Res. 2011;71(15):5296–5306. doi:10.1158/0008-5472.CAN-11-0156.
   PubMed Web of Science ®Google Scholar
• Palena C, Hamilton DH, Fernando RI. Influence of IL-8 on the epithelial–mesenchymal transition and the tumor microenvironment. Future Oncol. 2012;8(6):713–722. doi:10.2217/fon.12.59.
   PubMed Web of Science ®Google Scholar
• Ginestier C, Liu S, Diebel ME, Korkaya H, Luo M, Brown M, Wicinski J, Cabaud O, Charafe-Jauffret E, Birnbaum D, et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest. 2010;120(2):485–497. doi:10.1172/JCI39397.
   PubMed Web of Science ®Google Scholar
• Dominguez C, McCampbell KK, David JM, Palena C. Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer. JCI Insight. 2017;2(21):e94296. doi:10.1172/jci.insight.94296.
   PubMed Web of Science ®Google Scholar
• Najdaghi S, Razi S, Rezaei N. An overview of the role of interleukin-8 in colorectal cancer. Cytokine. 2020;135:155205. doi:10.1016/j.cyto.2020.155205.
   PubMed Web of Science ®Google Scholar
• Rippere-Lampe KE, O’Brien AD, Conran R, Lockman HA, Barbieri JT. Mutation of the gene encoding cytotoxic necrotizing factor Type 1 (cnf1) attenuates the virulence of uropathogenic Escherichia coli. Infect Immun. 2001;69(6):3954–3964. doi:10.1128/IAI.69.6.3954-3964.2001.
   PubMed Web of Science ®Google Scholar
• Loizzo S, Rimondini R, Travaglione S, Fabbri A, Guidotti M, Ferri A, Campana G, Fiorentini C, Ginsberg SD. CNF1 increases brain energy level, counteracts neuroinflammatory markers and rescues cognitive deficits in a murine model of Alzheimer’s disease. PLoS One. 2013;8(5):e65898. doi:10.1371/journal.pone.0065898.
   PubMed Web of Science ®Google Scholar
• The Society of Cells – Cancer and control of cell proliferation. C. Sonnenschein and A. M. Soto. Bios Scientific, Oxford, 1999. No. of pages: 154. Price: £18.95. ISBN: 1 85996 276 9 (US Publisher: SpringerVerlag, New York. Price: US $34.95. ISBN 0 387 91583 4.). J Patholo. 2000; 190:518–9. No. of pages: 154. Price: £18.95. ISBN: 1 85996 276 9 (US Publisher: SpringerVerlag, New York. Price: US $34.95. ISBN 0 387 91583 4.). J Patholo. 2000; 190:5189. No. of pages: 154. Price: £18.95. ISBN: 1 85996 276 9 (US Publisher: SpringerVerlag, New York. Price: US $34.95. ISBN 0 387 91583 4.). J Patholo. 2000; 190:5189
   Google Scholar
• Visvikis O, Boyer L, Torrino S, Doye A, Lemonnier M, Lorès P, Rolando M, Flatau G, Mettouchi A, Bouvard D, et al. Escherichia coli producing CNF1 toxin hijacks tollip to trigger Rac1-dependent cell invasion. Traffic. 2011;12(5):579–590. doi:10.1111/j.1600-0854.2011.01174.x.
   PubMed Web of Science ®Google Scholar
• Magalhaes YT, Farias JO, Silva LE, Forti FL. GTPases, genome, actin: a hidden story in DNA damage response and repair mechanisms. DNA Repair (Amst). 2021;100:103070. doi:10.1016/j.dnarep.2021.103070.
   PubMed Web of Science ®Google Scholar
• Huelsenbeck SC, Roggenkamp D, May M, Huelsenbeck J, Brakebusch C, Rottner K, Ladwein M, Just I, Fritz G, Schmidt G, et al. Expression and cytoprotective activity of the small GTPase RhoB induced by the Escherichia coli cytotoxic necrotizing factor 1. Int J Biochem Cell Biol. 2013;45(8):1767–1775. doi:10.1016/j.biocel.2013.05.020.
   PubMed Web of Science ®Google Scholar
• Ju JA, Gilkes DM. RhoB: team oncogene or team tumor suppressor? Genes (Basel). 2018;9:67. doi:10.3390/genes9020067.
   PubMed Web of Science ®Google Scholar
• Liu A-X, Rane N, Liu J-P, Prendergast GC. RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells. Mol Cell Biol. 2001;21(20):6906–6912. doi:10.1128/MCB.21.20.6906-6912.2001.
   PubMed Web of Science ®Google Scholar
• Chen Z, Sun J, Pradines A, Favre G, Adnane J, Sebti SM. Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice. J Biol Chem. 2000;275(24):17974–17978. doi:10.1074/jbc.C000145200.
   PubMed Web of Science ®Google Scholar
• Dubois D, Delmas J, Cady A, Robin F, Sivignon A, Oswald E, Bonnet R. Cyclomodulins in urosepsis strains of Escherichia coli. J Clin Microbiol. 2010;48(6):2122–2129. doi:10.1128/JCM.02365-09.
   PubMed Web of Science ®Google Scholar
• Fabian NJ, Mannion AJ, Feng Y, Madden CM, Fox JG. Intestinal colonization of genotoxic Escherichia coli strains encoding colibactin and cytotoxic necrotizing factor in small mammal pets. Vet Microbiol. 2020;240:108506. doi:10.1016/j.vetmic.2019.108506.
   PubMed Web of Science ®Google Scholar
• Tenaillon O, Skurnik D, Picard B, Denamur E. The population genetics of commensal Escherichia coli. Nat Rev Micro. 2010;8(3):207–217. doi:10.1038/nrmicro2298.
   PubMed Web of Science ®Google Scholar
• Datsenko KA, Wanner BL. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA. 2000;97(12):6640–6645. doi:10.1073/pnas.120163297.
   PubMed Web of Science ®Google Scholar
• Chaveroche MK, Ghigo JM, d’Enfert C. A rapid method for efficient gene replacement in the filamentous fungus Aspergillus nidulans. Nucleic Acids Res. 2000;28(22):97e–97. doi:10.1093/nar/28.22.e97.
   PubMed Web of Science ®Google Scholar